Altered Heparin Response Completed Phase 1 Trials for Antithrombin Alfa (DB11166)

IndicationStatusPhase
DBCOND0057516 (Altered Heparin Response)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01598883Understanding Heparin Resistance in Cardiac SurgeryBasic Science